logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Tanya Simuni 封面图

Tanya Simuni

northwestern university教授
H指数:63
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Progress towards a biotypic biomarker profile for amyotrophic lateral sclerosis–frontotemporal spectrum disorders

针对肌萎缩侧索硬化-额颞叶谱系障碍的表型生物标志物谱研究进展

Brain
IF11.7
2026-09-050
OAAI
Michael J Strong; Neil Donison; Ammar Al-Chalabi; Bradley Boeve; Elizabeth C Finger; Henne Holstege; Edward D Huey; Edward B Lee; Sarah J Marzi; Caroline McHutchison; Corey T McMillan; Markus Otto; Leonard Petrucelli; Mercedes Prudencio; Tanya Simuni; Maria Carmela Tartaglia; Martin R Turner; Philip Van Damme; David A Wolk
Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative

帕金森进展标志物研究队列中散发性帕金森病长期随访结局

Annals of Neurology
IF7.7
2026-05-180
PRE
Paulina Gonzalez-Latapi MD; Caroline Gochanour MS; Seung Ho Choi MS; Hyunkeun Cho PhD; Chelsea Caspell-Garcia MS; Christopher S. Coffey PhD; David-Erick Lafontant PhD; Yuge Xiao BS; Caroline M. Tanner MD; Charles S. Venuto PharmD; Karl Kieburtz MD; Lana M. Chahine MD; Kathleen L. Poston MD; Douglas Galasko MD; Marina Picillo MD; Andrew Siderowf MD; Thomas F. Tropea DO; Tanya Simuni MD; Kenneth Marek MD; the Parkinson's Progression Markers Initiative
Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative

帕金森病诊断前的个体识别与入组：基于生物标志物的适应性资格筛选与入组至帕金森进展标志物倡议

Annals of Neurology
IF7.7
2026-05-140
PRE
Ethan G. Brown MD; Lana M. Chahine MD; Roseanne D. Dobkin PhD; Tanya Simuni MD; Tatiana Foroud PhD; Laura E.A. Heathers BA; Thomas F. Tropea DO; Craig E. Stanley Jr PhD; Bridget A. McMahon BSN; Norbert Brüggemann MD; Christine Klein MD; Ronald B. Postuma MD; Noah S. Johnson MS; Caroline Gochanour MS; Chelsea Caspell-Garcia MS; Ryan Kurth MS; Michael C. Brumm MS; Christopher S. Coffey PhD; Kenneth Marek MD; Caroline M. Tanner MD; the Parkinson's Progression Markers Initiative
Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease

神经元synuclein疾病谱的招募策略

Annals of Neurology
IF7.7
2026-05-100
PRE
Andrew Siderowf MD; Laura E.A. Heathers BA; Kimberly Fabrizio BS; Maggie McGuire Kuhl BA; Catherine M. Kopil PhD; Emily Flagg BA; Bridget A. McMahon BSN; Christopher S. Coffey PhD; Audra Bright BS; Michelle Totten BS; Lynell P. Lemon PhD; Erinn Bryan BS; Neha Prakash MBBS; Nicola Pavese MD; Bastiaan R. Bloem MD; Roy N. Alcalay MD; Anat Mirelman PhD; Leonidas Stefanis MD; Njideka Okubadejo MD; Eduardo Tolosa MD; Caroline M. Tanner MD; Tanya Simuni MD; Sohini Chowdhury PhD; Thomas F. Tropea DO; Kenneth Marek MD; Tatiana Foroud PhD; the Parkinson's Progression Markers Initiative
How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early-Stage Neuronal Alpha-Synuclein Disease

PPMI如何支持了首个干预性平台试验，以测试早期神经元α-突触核蛋白疾病患者的疗法

Annals of Neurology
IF7.7
2026-05-070
PRE
Tanya Simuni MD; Christopher S. Coffey PhD; Catherine M. Kopil PhD; Cora Allen-Savietta PhD; Barbara Wendelberger PhD; Amy Crawford PhD; Ruth B. Schneider MD; Andrew Siderowf MD; Karl Kieburtz MD; Caroline M. Tanner MD; Thomas F. Tropea DO; Heidi Whalen MHS; Lianne Ramia BS; Cornelia Kamp MBA; Cecilia Reyes BS; Kimberly Fabrizio BA; Tawny Willson MS; Erika Merriam MHS; Maggie McGuire Kuhl BA; Sohini Chowdhury PhD; Kenneth Marek MD; Parkinson's Progression Markers Initiative
Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative

α-突触核蛋白病的生物学框架：帕金森进展标志物倡议的贡献

Annals of Neurology
IF7.7
2026-05-060
PRE
Lana M. Chahine MD; Roy N. Alcalay MD; Ethan G. Brown MD; Sohini Chowdhury MA; Christopher S. Coffey PhD; Tatiana Foroud PhD; Mark Frasier PhD; Douglas Galasko MD; Kalpana M. Merchant PhD; Brit Mollenhauer MD; Eduardo Tolosa MD; Nicola Pavese MD; Thomas F. Tropea DO; Kenneth Marek MD; Tanya Simuni MD; the Parkinson's Progression Markers Initiative
Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined Synucleinopathy

前驱期路易体障碍特征在具有生物标志物定义的突触核蛋白病中的快速眼动睡眠行为障碍

Annals of Clinical and Translational Neurology
IF3.9
2026-04-011
OAAI
Weintraub, Daniel; York, Michele K.; Dobkin, Roseanne; Nair, Anuprita R.; Kurth, Ryan; Lafontant, David-Erick; Caspell-Garcia, Chelsea; Alcalay, Roy N.; Brown, Ethan G.; Chahine, Lana M.; Coffey, Christopher; Foroud, Tatiana; Galasko, Douglas; Kieburtz, Karl; Marek, Kenneth; Merchant, Kalpana; Mollenhauer, Brit; Poston, Kathleen L.; Siderowf, Andrew; Simonet, Cristina; Simuni, Tanya; Tanner, Caroline M.; Tropea, Thomas F.; Videnovic, Aleksandar
A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data
PARKINSONISM & RELATED DISORDERS
IF3.4
2025-03-010
OAAI
Nikolcheva, Tania; Pagano, Gennaro; Pross, Nathalie; Simuni, Tanya; Marek, Kenneth; Postuma, Ronald B.; Pavese, Nicola; Stocchi, Fabrizio; Seppi, Klaus; Monnet, Annabelle; Shariati, Nima; Ricci, Benedicte; Rutten-Jacobs, Loes; Respondek, Gesine; Kustermann, Thomas; Taylor, Kirsten I.; Trundell, Dylan; Fontoura, Paulo; Doody, Rachelle; Svoboda, Hanno; Bonni, Azad; Prasinezumab Study Grp
Accelerating Parkinson's Disease drug development with federated learning approaches
NPJ PARKINSONS DISEASE
IF8.2
2024-11-210
OAAI
Khanna, Amit; Adams, Jamie; Antoniades, Chrystalina; Bloem, Bastiaan R.; Carroll, Camille; Cedarbaum, Jesse; Cosman, Joshua; Dexter, David T.; Dockendorf, Marissa F.; Edgerton, Jeremy; Gaetano, Laura; Goikoetxea, Erkuden; Hill, Derek; Horak, Fay; Izmailova, Elena S.; Kangarloo, Tairmae; Katabi, Dina; Kopil, Catherine; Lindemann, Michael; Mammen, Jennifer; Marek, Kenneth; Mcfarthing, Kevin; Mirelman, Anat; Muller, Martijn; Pagano, Gennaro; Peterschmitt, M. Judith; Ren, Jie; Rochester, Lynn; Sardar, Sakshi; Siderowf, Andrew; Simuni, Tanya; Stephenson, Diane; Swanson-Fischer, Christine; Wagner, John A.; Jones, Graham B.
Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial
NATURE MEDICINE
IF50
2024-10-080
OAAI
Pagano, Gennaro; Monnet, Annabelle; Reyes, Adriana; Ribba, Benjamin; Svoboda, Hanno; Kustermann, Thomas; Simuni, Tanya; Postuma, Ronald B.; Pavese, Nicola; Stocchi, Fabrizio; Brockmann, Kathrin; Smigorski, Krzysztof; Gerbaldo, Valentina; Fontoura, Paulo; Doody, Rachelle; Kerchner, Geoffrey A.; Brundin, Patrik; Marek, Kenneth; Bonni, Azad; Nikolcheva, Tania
Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts

PPMI，帕萨迪纳和SPARK基线队列中的神经元 α-突触核蛋白疾病综合分期系统性能

NPJ PARKINSONS DISEASE
IF8.2
2024-09-270
OAAI
Dam, Tien; Pagano, Gennaro; Brumm, Michael C.; Gochanour, Caroline; Poston, Kathleen L.; Weintraub, Daniel; Chahine, Lana M.; Coffey, Christopher; Tanner, Caroline M.; Kopil, Catherine M.; Xiao, Yuge; Chowdhury, Sohini; Concha-Marambio, Luis; Dibiaso, Peter; Foroud, Tatiana; Frasier, Mark; Jennings, Danna; Kieburtz, Karl; Merchant, Kalpana; Mollenhauer, Brit; Montine, Thomas J.; Nudelman, Kelly; Seibyl, John; Sherer, Todd; Singleton, Andrew; Stephenson, Diane; Stern, Matthew; Soto, Claudio; Tolosa, Eduardo; Siderowf, Andrew; Dunn, Billy; Simuni, Tanya; Marek, Kenneth; Parkinsons Progression Markers Initiative, Caroline

研究方向

暂未获取到该数据
L
Lana M. Chahine
H 指数:52论文数:254被引数:9,097
K
Kenneth Marek
H 指数:78论文数:430被引数:3.0万
A
Andrew Siderowf
H 指数:83论文数:362被引数:2.9万
D
Daniel Weintraub
H 指数:114论文数:625被引数:5.3万
B
Brit Mollenhauer
H 指数:90论文数:480被引数:3.9万
C
Caroline M. Tanner
H 指数:97论文数:456被引数:4.2万
C
Chelsea Caspell‐Garcia
H 指数:32论文数:76被引数:4,924
C
Christopher S. Coffey
H 指数:45论文数:192被引数:1.0万
T
Tatiana Foroud
H 指数:137论文数:1,168被引数:7.3万
K
Kathleen L. Poston
H 指数:49论文数:259被引数:9,346